Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 852 results found since Jan 2013.

Africa: Merck's HPV Vaccine Available in Africa Through Unicef Tender
[Merck]LUCERNE, Switzerland, May 9, 2013 -MSD, known as Merck in the United States and Canada, announced today that the company has been awarded a significant portion of the UNICEF human papillomavirus (HPV) vaccine tender, and will provide sustained supply of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] to GAVI-eligible countries. This agreement follows the GAVI Alliance's earlier announcement that HPV vaccines would be included in its po
Source: AllAfrica News: Health and Medicine - May 10, 2013 Category: African Health Source Type: news

New BUSM study explores providers' perceptions of parental concerns about HPV vaccination
(Boston University Medical Center) A new Boston University School of Medicine study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus, while white, middle-class parents are more likely to defer the vaccination.
Source: EurekAlert! - Social and Behavioral Science - May 14, 2013 Category: Global & Universal Source Type: news

Study Explores Providers' Perceptions Of Parental Concerns About HPV Vaccination
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents are more likely to defer the vaccination. The findings appear online in the May issue of the Journal of Health Care for the Poor and Underserved. Cervical cancer incidence and mortality are markedly higher for low-income and minority women due to higher rates of HPV and limited access to screening and treatment...
Source: Health News from Medical News Today - May 17, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

The first vaccine against cancer: the human papillomavirus vaccine.
Abstract The last 20 years is one of the most remarkable periods in the fight against cancer, with the realization that some human papillomaviruses are causally related to cancer and with the development of the vaccine against human papillomavirus infections. This is a historical event in medicine and the prophylactic human papillomavirus vaccines have provided powerful tools for primary prevention of cervical cancer and other human papillomavirus-associated diseases. This is very important as human papillomavirus infection is probably the most common sexually transmitted infection worldwide, and over one million ...
Source: Orvosi Hetilap - April 21, 2013 Category: Journals (General) Authors: Bősze P Tags: Orv Hetil Source Type: research

Zimbabwe: Treasury Fails Hospital
[The Herald]The Finance Ministry's delay in releasing funds is stalling the expansion of the vaccine storage facility at Parirenyatwa Group of Hospitals. This follows the proposed introduction of the human papilloma virus (HPV) vaccine which is expected to see a marked reduction of women who develop cervical cancer. Deputy Minister of Health and Child Welfare, Dr Douglas Mombeshora said: "The Ministry of Finance allocated US$500 000 for the expansion of the storage facilities at Parirenyatwa Hospital in the last two n
Source: AllAfrica News: Health and Medicine - June 8, 2013 Category: African Health Source Type: news

Understanding Human Papillomavirus Vaccination Intentions: Comparative Utility of the Theory of Reasoned Action and the Theory of Planned Behavior in Vaccine Target Age Women and Men
ConclusionClinical and public health education should focus on strengthening attitudes and perceptions of social support for HPV vaccination, and on the basic beliefs that appear to underlie attitudes and perceptions of social support for HPV vaccination, in efforts to promote HPV vaccine uptake. Fisher WA, Kohut T, Salisbury CMA, and Salvadori MI. Understanding human papillomavirus vaccination intentions: Comparative utility of the Theory of Reasoned Action and the Theory of Planned Behavior in vaccine target age women and men. J Sex Med **;**:**–**.
Source: The Journal of Sexual Medicine - June 1, 2013 Category: Sexual Medicine Authors: William A. Fisher, Taylor Kohut, Claire M.A. Salisbury, Marina I. Salvadori Tags: Original Research Source Type: research

HPV Vaccine Is Credited in Fall of Teenagers’ Infection Rate
The prevalence of dangerous strains of the human papillomavirus, a principal cause of cervical cancer, has dropped by half in the last decade, officials say.    
Source: NYT Health - June 19, 2013 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Human Papilloma Virus (HPV) Medicine and Health Source Type: news

Human papillomavirus infection prevalence and prevention
Human papillomaviruses (HPV) are classified into three genera and further categorized as high-risk (oncogenic), associated with malignancies such as cervical cancer, or low-risk (non-oncogenic), associated with benign diseases. Many oncogenic types are found in the oral cavity, but most HPV oral infections do not progress to neoplastic disease. The HPV types most often associated with benign genital and oral condylomas and papillomas are HVP 6 and 11. Those associated with oral warts and oral verrucas are HPV 13 and 32 and HPV 2 and 4, respectively. The oncogenic HPV types include HPV 16 and 18. Exposure to HPV infection i...
Source: Dental Abstracts - July 1, 2013 Category: Dentistry Tags: Oral Medicine Source Type: research

Physicians Slow To Implement HPV Vaccination And Cervical Cancer Screening Guidelines
Recent breakthroughs in cervical cancer prevention have resulted in new vaccination and cervical cancer screening guidelines. Recommendations do not always translate into practice, however. Less than one third of obstetrician-gynecologists vaccinate their eligible patients against the human papilloma virus (HPV), and only half adhere to cervical cancer prevention guidelines published three years previously, according to a survey published this month in the American Journal of Preventive Medicine. Vaccination against HPV has been recommended for women aged 1 - 26 years since 2006...
Source: Health News from Medical News Today - July 9, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

HPV vaccination to prevent anal cancer in men who have sex with men
Prevention of cancer remains a challenge in many areas of medicine. The discovery of the association of human papillomavirus (HPV) to anogenital cancers has led to the successful development of preventative vaccines. Men who have sex with men (MSM) are disproportionately affected by HPV-related cancer, particularly anal cancer, where rates are over 15 times higher than in heterosexual men (OR 17.3; 95% CI 8.2 to 36.1).1 This is driven by disease in HIV-positive MSM in whom the very high rates of anal cancer are increasing despite highly active antiretroviral treatment (HAART). The incidence of anal cancer during the HAART ...
Source: Sexually Transmitted Infections - July 15, 2013 Category: Sexual Medicine Authors: Lawton, M. D., Nathan, M., Asboe, D. Tags: Editorial Source Type: research

Sexual and reproductive health in a UK cohort of young adults perinatally infected with HIV
Conclusions The majority of our cohort was sexually active while still under the care of paediatric health services. Cervical screening and hepatitis B vaccination rates fell short of audit standards. Vaccination for hepatitis B should be considered prior to transfer of care to adult HIV services.
Source: Sexually Transmitted Infections - July 15, 2013 Category: Sexual Medicine Authors: Croucher, A. P., Jose, S., McDonald, S., Foster, C., Fidler, S. Tags: Liver disease, Drugs: infectious diseases, Hepatitis and other GI infections, HIV/AIDS, Vaccination / immunisation, Pregnancy, Reproductive medicine, Adolescent health, Child health, Hepatitis (sexual health), HIV / AIDS, HIV infections, Other viral STIs, Source Type: research

Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review).
Abstract Pterygium is a potentially vision-threatening fibrovascular lesion originating from the conjunctiva that often extends on the corneal surface. Although it has been extensively studied, its pathogenesis has yet to be fully elucidated. Recent evidence on molecular genetic abnormalities in pterygium suggested neoplastic changes of limbal stem cells potentially associated with exposure to ultraviolet (UV) light. Human papillomavirus (HPV) is an oncogenic virus, associated with squamo-proliferative lesions of the anogenital region, skin and oropharynx. Several studies have shown HPV involvement in the pathogen...
Source: International Journal of Molecular Medicine - July 12, 2013 Category: Molecular Biology Authors: Chalkia AK, Spandidos DA, Detorakis ET Tags: Int J Mol Med Source Type: research

Challenges in Cervical Cancer Prevention: A Survey of U.S. Obstetrician-Gynecologists
Conclusions: This survey of obstetrician-gynecologists indicates persistent barriers to the adoption of HPV vaccination and cervical cancer screening guidelines. Interventions to promote guideline adherence may help improve the quality of cervical cancer prevention.
Source: American Journal of Preventive Medicine - July 18, 2013 Category: Global & Universal Authors: Rebecca B. Perkins, Britta L. Anderson, Sherri Sheinfeld Gorin, Jay A. Schulkin Tags: Research Articles Source Type: research

HPV Vaccination in Female Children with Special Health Care Needs
Conclusions: This study suggests that acceptability of the HPV vaccine is high for health care providers, but acceptability in parents of CSHCN is lower than in the general population. This study raises awareness that health care providers need to be aware of the possibility that parents of CSHCN may not perceive their child as needing or being offered the HPV vaccine.
Source: Journal of Pediatric and Adolescent Gynecology - March 18, 2013 Category: OBGYN Authors: Paula J. Cody, Sarah J. Lerand Tags: Original Studies Source Type: research

Tanzania: Researcher Supports Cervical Cancer Vaccine Trials in Mwanza
[Daily News]LOCAL girls who have received Cervarix and Gardasil vaccines to prevent them from cervical cancer are doing well with only a single case of mild rush reaction noticed, an advisor with Mwanza Intervention Trials Unit, Dr Deborah Jones said in an email while responding to the 'Daily News on Saturday' questions.
Source: AllAfrica News: Health and Medicine - August 12, 2013 Category: African Health Source Type: news